© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
In this Peer Exchange, a panel of specialists examine the current and developing treatment options for age-related macular degeneration, with a focus on faricimab.
November 17th 2021
Nancy L. Holekamp, MD, defines age-related macular degeneration (AMD), while Jennifer I. Lim, MD, discusses signs and symptoms that are usually present in patients before diagnosis.
November 19th 2021
Carl Regillo, MD, FACS, discusses diagnosing patient with age-related macular degeneration.
Lloyd Clark, MD, provides examples of when clinicians should refer patients with AMD to specialists, and Carl Regillo, MD, FACS, explains the typical therapy goals a specialist has for each patient.
December 1st 2021
Lloyd Clark, MD, and Jennifer I. Lim, MD, give their insight into therapy considerations when deciding to use anti-VEGF agents to treat age-related macular degeneration.
Nancy M. Holekamp, MD, and Carl Regillo, MD, FACS, discuss the safety aspects of anti-VEGF agents when treating age-related macular degeneration.
December 13th 2021
Dr Clark details additional diagnostic tools he uses when deciding to use anti-VEGF agents, as well as his experience using the drug brolucizumab, and Dr Regillo elaborates on brolucizumab.
Drs Lim, Holekamp, and Regillo discuss the introduction of the drug faricimab as a therapy option for age-related macular degeneration and the data from the TEYANA and LUCERNE clinical trials.
December 14th 2021
Two specialists examine the YOSEMITE and RHINE clinical trials that explored faricimab as a therapeutic option for patients with both diabetes and age-related macular degeneration.
Two specialists give their insight into a VEGF inhibitor that could potentially be used as an effective treatment for age-related macular degeneration: port delivery system.
December 21st 2021
Lloyd Clark, MD, discusses a different VEGF inhibitor that could have a positive effect on age-related macular degeneration treatment: KSI-301.
New FMT Trial Halted Due to Effectiveness
Postponing Morning Rounds for Nurses May Lead to Sleep Improvement for Patients
Higher Risk of Suicide Observed in Adolescents Suffering from Nightmare Distress